AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline
AbbVie wasn’t a part of the primary wave of cell therapies developed for most cancers, however it's positioning itself to ...
Tag: 2.1B
RECOMMENDED
Certify Raises $40M To Advance Healthcare Provider Data Infrastructure
Certify, a supplier knowledge intelligence firm, has secured $40 million in Sequence B funding, bringing its whole funding up to...
Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.